February 4, 2013
The UCSF Center for Tobacco Control, Research and Education will host “It’s About A Billion Lives,” on Friday, Feb. 8. The annual event, which is open to the public, celebrates tobacco research and education efforts at the University.
January 30, 2013
Women with harmful mutations in the BRCA gene, which put them at higher risk of developing breast and ovarian cancer, tend to undergo menopause significantly sooner than other women, allowing them an even briefer reproductive window and possibly a higher risk of infertility, according to a study led by researchers at UC San Francisco.
January 28, 2013
The spread of breast cancer to distant organs within the body, an event that often leads to death, appears in many cases to involve the loss of a key protein, according to UC San Francisco researchers, whose new discoveries point to possible targets for therapy.
January 23, 2013
Nearly 100 UCSF faculty and staff turned out on January 8th for a Comparative Effectiveness Research (CER) and Patient-Centered Outcomes Research (PCOR) symposium hosted by the Comparative Effectiveness Research program at UCSF's Clinical and Translational Science Institute (CTSI).
January 23, 2013
With UCSF Mission Bay gleaming brighter every day, it's easy to forget a time when some UCSF researchers did not want to leave the hive of activity on the Parnassus Heights campus for entirely new labs across town in a once-forsaken neighborhood.
January 23, 2013
Ten years after the UCSF Mission Bay campus was established, UCSF Medical Center at Mission Bay – the key patient-care component of the campus – is only two years away from opening. Construction of the 289-bed state-of-the-art hospital complex for children, women and cancer patients is moving along swiftly, on schedule and on budget.
January 15, 2013
Ten core facilities on campus have been selected to receive a collective $2 million in funds from the Chancellor’s office to expand and improve access to transformative research technologies across UCSF.
January 9, 2013
Researchers in California and Switzerland have discovered that melanomas that develop resistance to the anti-cancer drug vemurafenib (marketed as Zelboraf), also develop addiction to the drug, an observation that may have important implications for the lives of patients with late-stage disease.
January 7, 2013
The National Cancer Institute (NCI) has awarded the UCSF Helen Diller Family Comprehensive Cancer Center a $36 million grant to support cutting-edge research programs and clinical trials over five years.
January 4, 2013
The most comprehensive retrospective study ever conducted comparing how the major types of prostate cancer treatments stack up to each other in terms of saving lives and cost effectiveness is reported this week by a team of researchers at UCSF.
Copyright © 2013-2014 University of California Regents. All Rights Reserved.
UCSF Helen Diller Family Comprehensive Cancer Center
Site Map | Terms of Use & Privacy Policy | Contact Webmaster
Subscribe to RSS